July 2004
"ISPOR e-BULLETIN" provides updates of recent ISPOR activities and events. For detailed information on ISPOR activities, members are encouraged to go to www.ispor.org.
 

Please pass these updates along to your colleagues.

  eBulletin Index

  

NEW THIS MONTH

**NEW**     Over 650 scientific research abstracts submitted for the ISPOR 7th Annual European Congress in Hamburg, Germany, 24-26, October 2004!

**COMING SOON** Value in Health, Vol. 7, Issue 4 (July/August) featured article – Discounting Health Outcomes in Economic Evaluation: The Ongoing Debate

**NEW**    ISPOR CONNECTIONS, Vol. 10 No. 3 May/June 2004, featuring summary of the ISPOR 9th Annual International Meeting (with pictures!)

**UPDATE** ISPOR Bernie J. O‘Brien New Investigator Award – An Endowed Award

**NEW**      ISPOR Student Chapter – Purdue University Student Chapter

**NEW**    "Pharmacoeconomic Guidelines Around the World" at the ISPOR web site

**COMING SOON** ISPOR Distance Learning Program on the ISPOR website

 

 

ISPOR ONGOING ACTIVITIES

 

1.       Publications

2.       Meetings and Congresses

3.       Educational Activities

4.       Student News

5.       ISPOR Special Interest Groups

6.       Committee and Task Force Activities

7.       Hot Topics

8.       Important Dates to Remember

9.       Employment in Pharmacoeconomics and Outcomes Research

10.    Membership

 


  1. PUBLICATIONS

Top

 

 

VALUE IN HEALTH

 

Value in Health: Volume 7, Issue 4, July/August 2004 will be available later this month at: http://www.ispor.org/valueinhealth_index.asp. 

 

 Featured in this issue . . .

 

DISCOUNTING HEALTH OUTCOMES IN ECONOMIC EVALUATION: THE ONGOING DEBATE

      Johan L. Severens and Richard J Milne

 

Johan Severens from the University Hospital Maastricht and Richard Milne from the University of Auckland, in a review of the ongoing debate on discount rates conclude: “Ideally, the discount rate for the costs and health outcomes from health care interventions should be based on actual measures of social time preference.  Since this research takes too much time, national values should be determined by national panels, as international values are doomed to fail.”

 

There is on ongoing debate regarding the different mathematical methods of discounting future outcomes of health care interventions to ‘present value’. Contrasting methods are uniform discounting (using the same discount rate for health benefits as is used for costs, e.g. 3% in the US) versus differential discounting (e.g. 6% for costs and 2% for health benefits) and constant versus time-varying discount rates (e.g.. 3% for each year in the future, versus 3% over the next 10 years and 1.5% after that). The choice of social discounting practice as a basis for rational choices regarding health care resources has a substantial impact on the cost-effectiveness estimates of health care programmes for which most of the costs are incurred in the near future and health benefits occur in the distant future. The commonly used method of uniform discounting leads to a prioritising of immediate treatment at the expense of long term health-care interventions.

 

Empirical findings show that individuals’ discount rates for costs and health outcomes vary   particularly for health outcomes and estimation of a social discount rate is, therefore difficult. Individuals report higher time preferences regarding the near future supporting time-varying discounting.

 

 

 ISPOR CONNECTIONS

 

ISPOR CONNECTIONS: Volume 10, Issue 3, May/June 2004 is now available to the public at: http://www.ispor.org/news/index_new.asp.  In this issue:

 

Outgoing Presidential Address

Sean Sullivan, PhD, University of Washington, Seattle, WA, USA

 

ISPOR 9th Annual Meeting Summary

 

ISPOR 9th Annual Meeting Short Courses

 

ISPOR 9th Annual Meeting Award Recipients

 

ISPOR 9th Annual Meeting Photo Gallery

 

HEALTH CARE COST, QUALITY, AND OUTCOMES: ISPOR BOOK OF TERMS

 

This ISPOR publication includes more than 100 detailed monographs covering over 400 terms used in health care delivery, management, and regulation, as well as health care outcomes research including clinical, economic, and quality-of-life research terms. ISPOR member discounted price is $36.00; a 40% discount!  Student/Library/Academic discounted price: $33.00 (a 45% discount). On-line ordering is now available at: http://www.ispor.org/publications/lexicon_index.asp.  Contact Stephen Priori at spriori@ispor.org for information on orders over 1000.

 


 

 

  1. ISPOR MEETINGS AND CONGRESSES

Top

  

 

ISPOR 7TH ANNUAL EUROPEAN CONGRESS

24-26 October 2004, CCH Congress Centrum Hamburg, Hamburg, Germany

 

Early Registration Deadline: 28 September 2004

 

MEETING AT A GLANCE

http://www.ispor.org/congresses/germany1004/index.asp

 

Sign up for Exhibit Space, contract available online a

Sponsorship Opportunities still available, for more information go to

 


 

  1. EDUCATION ACTIVITIES

Top

            ISPOR 7th Annual European Congress Short Courses

Saturday Short Courses, 23 October: http://www.ispor.org/congresses/germany1004/sc231004.asp

            Sunday Short Courses, 24 October:

http://www.ispor.org/congresses/germany1004/sc241004.asp

 

 **COMING SOON** ISPOR Distance Learning Program on the ISPOR website available Tuesday, July 13!

            Go to the ISPOR home page www.ispor.org

The following modules will be available:

 

 Pharmacoeconomics

  • The Role of Pharmacoeconomics (FREE)

 

Pharmacoeconomic Evaluations &  Methods

  • Cost Analysis in Pharmacoeconomics (I) – The Classification of Costs
  • Cost Analysis in Pharmacoeconomics (II) – The Health Care Production Function
  • An Introduction to Decision Theory
  • Markov Modeling in Decision Analysis
  • Evaluating a Pharmacoeconomic Study
  • Discounting Costs and Benefits
  • Modeling in Pharmacoeconomics

 

Cost-Effectiveness Analysis

  • Cost-Effectiveness Modeling in Pharmacoeconomics  
  • Interpreting Cost-Effectiveness Claims

 

Cost-Benefit Analysis

  • Theoretical Foundations of Cost Benefit Analysis
  • Measuring Willingness-to-Pay

 

Cost-Utility Analysis

  • Theoretical Foundations of Cost-Utility Analysis
  • Measuring Values and Utilities
  • Quality Adjusted Life Years (QALYs)

 

Humanistic Outcomes (Utilities, Health-related Quality of Life, Patient-reported Outcomes, Patient Preferences)

  • A Typology of Outcomes Instruments
  • The SF-36 Instrument
  • The Health Utilities Index

 

Study Design in Pharmacoeconomics

  • Study Design in Pharmacoeconomic Analysis
  • Experimental Designs
  • Non-Experimental Designs

 

Guidelines and Reference Standards

  • Guidelines and Reference Standards in Pharmacoeconomics
  • The Australian Guidelines for Formulary Submissions
  • Managed Care Formulary Submission Guidelines in the United States 
  • Responding to Managed Care Guidelines in the United States
  • Guidelines Case Study: Blue Cross and Blue Shield of Colorado and Nevada

 


 

 

  1. STUDENT NEWS

Top

 

  **NEW** ISPOR STUDENT CHAPTER

 

We welcome the new I Purdue University ISPOR Student Chapter led by Chapter President, Hemant Phatak, MS.

 

ISPOR PARTICIPATES IN SOUTHERN PHARMACY ADMINISTRATION CONFERENCE HELD IN FORT LAUDERDALE, FLORIDA, USA

 

ISPOR was represented proudly at this year’s conference by Larry Humble, Student Network Chair, who hosted the ISPOR booth to promote ISPOR membership, benefits, and answered any questions from potential new members concerning ISPOR and its upcoming events.

           


 

 

  1. ISPOR SPECIAL INTEREST GROUPS (SIG)

Top

 

 

WELCOME to the ISPOR members who joined the following NEW SIG Working Groups!

 

 

CLINICAL PRACTICE SIG

 

The Clinical Practice SIG reorganized around the theme: Dataset to Bedside. Projects in development for the next year:


Education Working Group:

  • A one-hour scripted slide show for clinicians on the basics of pharmacoeconomics and application of outcomes research.

 

PE/OR Research to Practice Working Group

  • A ‘clinical track’ contributed issue panel / workshop / presentation at Annual Meeting Topic: translation of research into clinical recommendations.

 

Standardized Reporting Working Group

  • Develop a standardized reporting format for outcomes research or economic evaluations designed for clinicians’ use.

 

    For more details, please visit: http://www.ispor.org/sigs/sigsindex.asp

 

RISK MANAGEMENT SIG UPDATE

 

The new Risk Management SIG identified projects for the next year:

 

Identification of Risk

  • Development of best practices for measurement, analysis, and assessment
  • Developed a database on costs/benefits of  health care treatments 

 

Communication Working Group

  • Identify different sources of information used by individuals and other stakeholders
  • Who uses risk information
  • How perceptions of risk are shaped

 

      Assess the effectiveness of different forms of information

  • Establish risk-reporting standards
  • Balancing risk and benefits of health care interventions
     

Identify mechanisms to improve risk communication and perceptions

  • Multi-disciplinary approaches
  • Professional organizations
  • Media interactions - guided tour of the ISPOR meeting
  • Individuals
     

Interventions/Implementation Working Group

  • How to fit risk management into the health care system
     

What interventions are best

  • Guidelines
  • Regulation
  • How to measure the risks and benefits of the intervention
  • Good practice models
     

Legal and Regulatory Implications Working Group

  • National Institute for Clinical Excellence ( UK)
     

Food and Drug Administration (US)

  • Institutional Review Boards
  • Data Safety and Monitoring Boards
  • Privacy relations (HIPPA)

 

For more details, please visit: http://www.ispor.org/sigs/rm.asp

 

MEDICATION COMPLIANCE SIG

            For more details, please visit: http://www.ispor.org/sigs/medication.asp

 

QUALITY OF LIFE SIG

            For more details, please visit: http://www.ispor.org/sigs/qol.asp


PATIENT REGISTRY SIG

 

                For more details, please visit: http://www.ispor.org/sigs/patient_registr.asp

 

Special Interest Group membership is open to ALL ISPOR members.

To JOIN any SIG: http://www.ispor.org/sigs/joinsig.htm

 


 

 

  1. ISPOR COMMITTEE AND TASK FORCE ACTIVITIES

Top

 

 

AWARD COMMITTEE ACTIVITIES

 

**UPDATE** ISPOR Bernie J. O‘Brien New Investigator Award – An Endowed Award

 

 

This past Spring, ISPOR created the ISPOR Bernie J. O’Brien New Investigator Award, an endowed award. This Award is to honor the long-standing commitment of Bernie to training and mentoring new scientists in the fields of outcomes research and pharmacoeconomics. A description, criteria, selection process, and nature of this award are at the ISPOR website at: http://www.ispor.org/awards/Obrien_investigator.asp.

 

Bernie O'Brien PhD, Professor, Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Canada passed away in February. Bernie was Chair of the ISPOR 9th Annual International Meeting to be held in May this year in Arlington, VA, USA and a recipient of the ISPOR Research Excellence Award in 2002.

 

To date, ISPOR has received over $25,000 in donations for this award!

 

We invite you to contribute to this ISPOR Award endowment.  Please note that one-half of the contributions received for this endowed award will be given to the Emma and Lucy O'Brien Trust Fund (Emma and Lucy are Bernie’s daughters).

 

If you are interested in contributing to the ISPOR Bernie J. O’Brien New Investigator Award Endowment, please email your interest to endowment@ispor.org.

 

We hope that you will donate to this endowment and lasting memory to Bernie and his ideals.

 

 

RANDOMIZED CLINICAL TRIALS ALONGSIDE COST EFFECTIVENESS ANALYSIS (RCT-CEA) TASK FORCE

 

Slides from the RCT-CEA Forum held at the ISPOR 9th Annual International meeting in May are now available on our website http://www.ispor.org/workpaper/clinical_trial.asp. 

 

The final presentation of this task force will be held at the 7th Annual European Congress to be held October 24-26, 2004 in Hamburg, Germany.

 

The ISPOR RCT-CEA Best Practices draft paper will be then be submitted to the Reference Group for concensus review after the 7th Annual European Congress and will be published in  Value in Health’ s July/August 2005 edition. 


  1. HOT TOPICS

Top

 

MEDICARE TAKES FURTHER STEPS TO PROMOTE THE USE OF HIPAA STANDARDS FOR ELECTRONIC CLAIMS

 

WASHINGTON, D.C. – Electronic Medicare claims that do not meet Health Insurance Portability and Accountability Act (HIPAA) standards will be treated as paper claims and paid more slowly than HIPAA-compliant electronic claims beginning this week, Mark B. McClellan, M.D., Ph.D., administrator of the Centers for Medicare & Medicaid Services (CMS) reminded today.

 

For full text of the article, go to: http://www.cms.hhs.gov/media/press/release.asp?Counter=1101

 

 

**NEW** "Pharmacoeconomic Guidelines around the World"

 

The International Society for Pharmacoeconomics and Outcomes Research is proud to present "Pharmacoeconomic Guidelines around the World" now available at the ISPOR website at: http://www.ispor.org/PEguidelines/index.asp. This quick reference guide includes 21 pharmacoeconomic guidelines and 6 submission guidelines for formulary listing from 23 countries as well as 1 journal guideline.

 

This quick reference guide contains a comparison of 32 key guideline features such as time horizon, effectiveness versus efficacy, financial impact analysis. Most of the country-specific guidelines can be reached by a hyperlink to the actual document. Just select the country at: http://www.ispor.org/PEguidelines/COUNTRYSPECIFIC.asp and hyperlink to the document.

 

To compare key features among different countries, use the comparative table at: http://www.ispor.org/PEguidelines/COMP1.asp. Select the countries of interest, then from the 32 key features, select your features of interest.

 

If you would like to add a pharmacoeconomic guideline or a submission guideline for formulary listing, please email your request to: peguideline@ispor.org.

 


 

 

  1. IMPORTANT DATES TO REMEMBER

Top

September 1, 2004 - Deadline to submit ads to be included in the 7th Annual European Congress final program brochure.

 

September 28, 2004Early registration deadline for the 7th Annual European Congress.  For register, go to: http://www.ispor.org/members/events/closed.asp

           

            October 1, 2004 – ISPOR 10th Annual International Meeting Abstract Submission begins.

 

October 24-26, 2004 – ISPOR 7th Annual European Congress, CCH Congress Centrum Hamburg, Hamburg, Germany.

           

            January 10, 2005 ISPOR 10th Annual International Meeting Abstract Deadline.


  1. EMPLOYMENT

Top

 

**NEW** 6 new positions posted since the last ebulletin. Careers

 

Advertise your positions on ISPOR Web (up to 1 million hits per month)

 

For information on PRAP at the 7th Annual European Congress, go to: Careers

 


  1. ISPOR MEMBERSHIP

Top

Update your email address at https://www.ispor.org/members/MemberProfile.aspx! Your email address is required as part of your log in information in the members only section of the ISPOR website.

 

 


eBulletin Index